Venter Pharma S.L.

Hypolactasia Diagnostics

Venter Pharma S.L. focuses on clinical research related to the diagnosis of hypolactasia, with attention to identifying markers that help distinguish reduced lactase activity from normal intestinal function.

  • Urinary xylose measurement
  • Intestinal lactase activity
  • Diagnostic cut-off points

The sponsor’s work in this area is centred on clinical evaluation in both adult and paediatric populations, supporting diagnostic assessment for lactose-related disorders.

Lactose Intolerance in Paediatric Care

Another key area of interest is lactose intolerance in children, including research aimed at improving the clinical interpretation of symptoms associated with impaired lactose digestion.

  • Paediatric symptom assessment
  • Normolactasic versus hypolactasic classification
  • Non-invasive diagnostic evaluation

This therapeutic domain reflects a focus on childhood digestive disorders where accurate diagnosis is important for guiding dietary management.

Gaxilose-Based Clinical Evaluation

The sponsor funds studies involving Gaxilose as part of the diagnostic investigation of lactase deficiency, with research spanning healthy volunteers and patients presenting clinical signs of lactose intolerance.

  • Oral diagnostic agents
  • Urinary biomarker analysis
  • Healthy volunteer assessment

These activities place emphasis on gastrointestinal diagnostic tools that support the detection of altered carbohydrate digestion.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness of Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5 to 11 Years

    Recruiting

    1 1 1 1
    Spain
  • Study on Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5-11

    Not recruiting

    1 1 1
    Spain